Cambridge Epigenetix
Latest round
- Series D
Last raised
- Nov 2021
Total raised
- $150M
Investors
- 9
About Cambridge Epigenetix
Founded in 2012 and based in Cambridge, UK, Cambridge Epigenetix Limited offers advanced solutions for genomic studies.Cambridge Epigenetix Limited primarily offers the duet multiomics solution evoC, designed for comprehensive analysis of genetic and epigenetic information from a minimal DNA sample. The technology identifies a 6-base genome, differentiating traditional DNA bases from key epigenetic modifications, such as 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC).10.73 million will support the further advancement and commercialization of Cambridge Epigenetix Limited's DNA-sequencing technology platform. The company aims to expand its product offerings and penetrate new markets, leveraging its innovative solutions to address growing demands in genomic and epigenetic research.
Who invested in Cambridge Epigenetix
9 investors across 4 rounds
See all investors in Cambridge Epigenetix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cambridge Epigenetix
Who invested in Cambridge Epigenetix?
Cambridge Epigenetix has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cambridge Epigenetix raised?
Cambridge Epigenetix has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Cambridge Epigenetix last raise money?
Cambridge Epigenetix's most recent round on record is a Series D, in Nov 2021.
What does Cambridge Epigenetix do?
Founded in 2012 and based in Cambridge, UK, Cambridge Epigenetix Limited offers advanced solutions for genomic studies.
Where is Cambridge Epigenetix headquartered?
Cambridge Epigenetix is headquartered in Cambridge, UK.
Which VCs invest in companies like Cambridge Epigenetix?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Cambridge Epigenetix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Cambridge Epigenetix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.